BUSA — Brandes U.S. Value ETF

Is BUSA overbought or oversold? Here is the current MarketMoodz read.

Overbought As of August 19, 2026

Brandes U.S. Value ETF (BUSA) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The stock last closed at $41.88. The rating moved from Neutral to Overbought on August 7, 2026.

AI analysis

An actively managed U.S. value ETF providing diversified exposure to economically sensitive and value-oriented equities. Near-term performance will likely track the degree of rotation into cyclicals and be influenced by macro signals around growth and rates.

Key factors

  • Broad U.S. value exposure that benefits from cyclical and economically sensitive sectors
  • Diversification across many large- and mid-cap value names reduces single-stock risk
  • Active value management (Brandes) can exploit valuation dislocations versus passive peers
  • Current market tone shows modest rotation into cyclicals, which supports value category performance
  • ETF structure offers tax efficiency and intraday liquidity compared with mutual funds
  • Lower sensitivity to growth sector volatility as holdings skew toward value-oriented balance sheets

Risks

  • Prolonged growth-led market leadership could drive persistent underperformance relative to growth benchmarks
  • Rising interest rates or unexpected monetary tightening that compresses valuations of dividend-paying/value stocks
  • Concentration risk if value holdings cluster in a few cyclical sectors (energy, financials, industrials)
  • Market volatility or risk-off shocks that trigger rapid re-pricing of cyclicals
  • Active-manager execution risk relative to passive value ETFs or benchmarks
  • Limited social/research sentiment visibility and lack of recent company-specific filings or disclosures in the provided data

See today's live rating, score and targets

Members see the live hourly rating for BUSA — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.